Investor Centre

In accordance with Listing Rule 3.10.3, Pharmaxis advises that the directors have resolved to grant 30,000 fully paid but restricted ordinary shares to Mr Richard van den Broek, in connection with his appointment as a Non Executive Director earlier this year.